Ajanta Pharma Ltd. (AJANTPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 178818, "name": "Ajanta Pharma", "stock_name": "Ajanta Pharma", "full_name": "Ajanta Pharma Ltd.", "name_url": "stocks-analysis/ajanta-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,972.00", "chg": 25.85, "chgp": "0.88%", "dir": 1, "prev_price": "2,946.15", "mcapval": "36,584.00 Cr", "mcap": "Small Cap", "scripcode": 532331, "symbol": "AJANTPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE031B01049", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "1.17 lacs", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajanta-pharma-178818-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Ajanta Pharma Ltd. is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-ltd-is-rated-buy-3904888", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_mojoScore_3904888.png", "date": "2026-03-21 10:10:25", "description": "Ajanta Pharma Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "Ajanta Pharma’s Technical Momentum Shifts Amid Mixed Signals: -0.14% Weekly Change", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharmas-technical-momentum-shifts-amid-mixed-signals--014-weekly-change-3892409", "imagepath": "", "date": "2026-03-15 15:01:32", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Downgrade to Hold by MarketsMOJO amid mixed technical and valuation signals</p>\n <p><strong>4 Mar:</strong> Technical momentum shifts to mildly bullish with mixed indicator signals</p>\n <p><strong>6 Mar:</strong> Technical momentum upgrades to bullish despite market volatility</p>\n <p><strong>6 Mar:</strong> Week closes at Rs.2,990.90 (-0.14%) outperforming Sensex (-3.00%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,995.00</div></div>\n <div class=\"stat-item\"..." }, { "title": "Ajanta Pharma Gains 1.27%: 4 Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-gains-127-4-key-factors-driving-the-weekly-rally-3891464", "imagepath": "", "date": "2026-03-14 16:03:15", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 09:</strong> Rating upgraded to Buy by MarketsMOJO</p>\n <p><strong>Mar 11:</strong> New 52-week high at Rs. 3,077.95</p>\n <p><strong>Mar 12:</strong> Further 52-week high at Rs. 3,148.6</p>\n <p><strong>Mar 13:</strong> New 52-week high at Rs. 3,158.2 despite intraday weakness</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,933.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.3,028.90</div><div class=\"stat-change posit..." }, { "title": "Ajanta Pharma Ltd. Hits New 52-Week High at Rs. 3,158.2", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs-31582-3888468", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_priceRelatedfactors_3888468.png", "date": "2026-03-13 09:47:38", "description": "Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today by hitting a new 52-week high of Rs. 3,158.2. This achievement underscores the stock’s strong momentum over the past year, reflecting robust financial performance and sustained investor confidence amid a challenging market backdrop." }, { "title": "Ajanta Pharma Ltd. Hits New 52-Week High at Rs.3148.6", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs31486-3887144", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_priceRelatedfactors_3887144.png", "date": "2026-03-12 14:44:59", "description": "Ajanta Pharma Ltd. reached a significant milestone today by hitting a new 52-week high of Rs.3148.6, marking a notable achievement in its stock performance amid a challenging broader market environment." }, { "title": "Ajanta Pharma Ltd. Hits New 52-Week High at Rs. 3,077.95", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs-307795-3885024", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_priceRelatedfactors_3885024.png", "date": "2026-03-11 10:44:57", "description": "Ajanta Pharma Ltd. has reached a significant milestone by hitting a new 52-week high of Rs 3,077.95, marking a notable surge in its stock price amid a challenging broader market environment." }, { "title": "Ajanta Pharma Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-upgraded-to-buy-on-strong-technical-and-financial-performance-3882075", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_mojoScore_3882075.png", "date": "2026-03-10 08:11:55", "description": "Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy by MarketsMOJO as of 9 March 2026. This upgrade reflects improvements across technical indicators, valuation metrics, financial trends, and overall quality, signalling renewed investor confidence despite a recent minor price dip." }, { "title": "Ajanta Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-market-volatility-3875095", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_technicaldot_3875095.png", "date": "2026-03-06 08:00:17", "description": "Ajanta Pharma Ltd. has witnessed a notable shift in its technical parameters, moving from a mildly bullish to a bullish trend, signalling renewed momentum in the Pharmaceuticals & Biotechnology sector. This change is underpinned by strong weekly and monthly MACD readings, bullish daily moving averages, and a positive price action that outpaces broader market indices, despite mixed signals from other technical indicators." }, { "title": "Ajanta Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3868033", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_technicaldot_3868033.png", "date": "2026-03-04 08:00:54", "description": "Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in its share price to ₹2,970 from the previous close of ₹2,995, the stock continues to demonstrate resilience amid mixed signals from various technical indicators, prompting a reassessment of its near-term outlook." } ], "total": 624, "sid": "178818", "stock_news_url": "https://www.marketsmojo.com/news/ajanta-pharma-178818" }, "announcements": [ { "caption": "Participation In Investor Conference", "datetime": "09-Mar-2026", "details": "Pls find enclosed intimation w.r.t Participation in Investor Conference.", "source": "BSE" }, { "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.", "datetime": "06-Mar-2026", "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 06 2026 for Aayush Agrawal Trustee Aayush Agrawal Trust", "source": "BSE" }, { "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.", "datetime": "23-Feb-2026", "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on February 23 2026 for Aayush Agrawal Trustee Aayush Agrawal Trust", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Ajanta Pharma Ltd. has declared <strong>1400%</strong> dividend, ex-date: 10 Nov 25", "dt": "2025-11-10", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Ajanta Pharma Ltd. has announced <strong>2:5</strong> stock split, ex-date: 20 Mar 15", "dt": "2015-03-20", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Ajanta Pharma Ltd. has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 22", "dt": "2022-06-22", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 09: Rating upgraded to Buy by MarketsMOJO

Mar 11: New 52-week high at Rs. 3,077.95

Mar 12: Further 52-week high at Rs. 3,148.6

Mar 13: New 52-week high at Rs. 3,158.2 despite intraday weakness

Read full news article

Ajanta Pharma Ltd. Hits New 52-Week High at Rs. 3,158.2

2026-03-13 09:47:38

Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today by hitting a new 52-week high of Rs. 3,158.2. This achievement underscores the stock’s strong momentum over the past year, reflecting robust financial performance and sustained investor confidence amid a challenging market backdrop.

Read full news article

Ajanta Pharma Ltd. Hits New 52-Week High at Rs.3148.6

2026-03-12 14:44:59

Ajanta Pharma Ltd. reached a significant milestone today by hitting a new 52-week high of Rs.3148.6, marking a notable achievement in its stock performance amid a challenging broader market environment.

Read full news article

Ajanta Pharma Ltd. Hits New 52-Week High at Rs. 3,077.95

2026-03-11 10:44:57

Ajanta Pharma Ltd. has reached a significant milestone by hitting a new 52-week high of Rs 3,077.95, marking a notable surge in its stock price amid a challenging broader market environment.

Read full news article

Ajanta Pharma Upgraded to Buy on Strong Technical and Financial Performance

2026-03-10 08:11:55

Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy by MarketsMOJO as of 9 March 2026. This upgrade reflects improvements across technical indicators, valuation metrics, financial trends, and overall quality, signalling renewed investor confidence despite a recent minor price dip.

Read full news article

Ajanta Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility

2026-03-06 08:00:17

Ajanta Pharma Ltd. has witnessed a notable shift in its technical parameters, moving from a mildly bullish to a bullish trend, signalling renewed momentum in the Pharmaceuticals & Biotechnology sector. This change is underpinned by strong weekly and monthly MACD readings, bullish daily moving averages, and a positive price action that outpaces broader market indices, despite mixed signals from other technical indicators.

Read full news article

Ajanta Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-04 08:00:54

Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in its share price to ₹2,970 from the previous close of ₹2,995, the stock continues to demonstrate resilience amid mixed signals from various technical indicators, prompting a reassessment of its near-term outlook.

Read full news article